PubMed

Immunolocalization of RANKL is increased and OPG decreased during dietary magnesium deficiency in the rat.

Rude RK, Gruber HE, Wei LY, Frausto A.

Nutr Metab (Lond). 2005 Sep 14;2(1):24.PMID: 16162295 [PubMed]Related articlesFree article

Skeletal and hormonal effects of magnesium deficiency.

Rude RK, Singer FR, Gruber HE.

J Am Coll Nutr. 2009 Apr;28(2):131-41. Review.PMID: 19828898 [PubMed - indexed for MEDLINE]Related articles

Age of donor alters the effect of cyclic hydrostatic pressure on production by human macrophages and osteoblasts of sRANKL, OPG and RANK.

Evans CE, Mylchreest S, Andrew JG.

BMC Musculoskelet Disord. 2006 Mar 6;7:21.PMID: 16519799 [PubMed - indexed for MEDLINE]Related articlesFree article

Osteoblasts provide a suitable microenvironment for the action of receptor activator of nuclear factor-kappaB ligand.

Yamamoto Y, Udagawa N, Matsuura S, Nakamichi Y, Horiuchi H, Hosoya A, Nakamura M, Ozawa H, Takaoka K, Penninger JM, Noguchi T, Takahashi N.

Endocrinology. 2006 Jul;147(7):3366-74. Epub 2006 Apr 20.PMID: 16627581 [PubMed - indexed for MEDLINE]Related articlesFree article

Inhibition of hormone and cytokine-stimulated osteoclastogenesis and bone resorption by interleukin-4 and interleukin-13 is associated with increased osteoprotegerin and decreased RANKL and RANK in a STAT6-dependent pathway.

Palmqvist P, Lundberg P, Persson E, Johansson A, Lundgren I, Lie A, Conaway HH, Lerner UH.

J Biol Chem. 2006 Feb 3;281(5):2414-29. Epub 2005 Oct 25.PMID: 16251181 [PubMed - indexed for MEDLINE]Related articlesFree article

The HLA-B27 transgenic rat, a model of spondyloarthritis, has decreased bone mineral density and increased RANKL to osteoprotegerin mRNA ratio.

Rauner M, Stupphann D, Haas M, Fert I, Glatigny S, Sipos W, Breban M, Pietschmann P.

J Rheumatol. 2009 Jan;36(1):120-6.PMID: 19040304 [PubMed - indexed for MEDLINE]Related articles

The differential expression of osteoprotegerin (OPG) and receptor activator of nuclear factor kappaB ligand (RANKL) in human osteoarthritic subchondral bone osteoblasts is an indicator of the metabolic state of these disease cells.

Kwan Tat S, Pelletier JP, Lajeunesse D, Fahmi H, Lavigne M, Martel-Pelletier J.

Clin Exp Rheumatol. 2008 Mar-Apr;26(2):295-304.PMID: 18565252 [PubMed - indexed for MEDLINE]Related articles

Alteration of bone cell function by RANKL and OPG in different in vitro models.

Lin JM, Callon KE, Lin CQ, Bava U, Zheng MH, Reid IR, Cornish J.

Eur J Clin Invest. 2007 May;37(5):407-15.PMID: 17461987 [PubMed - indexed for MEDLINE]Related articles

CLINICAL Review #: the role of receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/osteoprotegerin: clinical implications.

Vega D, Maalouf NM, Sakhaee K.

J Clin Endocrinol Metab. 2007 Dec;92(12):4514-21. Epub 2007 Sep 25. Review.PMID: 17895323 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of the RANKL inhibitor, osteoprotegerin, on the pain and histopathology of bone cancer in rats.

Roudier MP, Bain SD, Dougall WC.

Clin Exp Metastasis. 2006;23(3-4):167-75. Epub 2006 Aug 16.PMID: 16912914 [PubMed - indexed for MEDLINE]Related articles

Effect of low-level laser treatment after installation of dental titanium implant-immunohistochemical study of RANKL, RANK, OPG: an experimental study in rats.

Kim YD, Kim SS, Hwang DS, Kim SG, Kwon YH, Shin SH, Kim UK, Kim JR, Chung IK.

Lasers Surg Med. 2007 Jun;39(5):441-50.PMID: 17523169 [PubMed - indexed for MEDLINE]Related articles

Characterization of osteoprotegerin binding to glycosaminoglycans by surface plasmon resonance: role in the interactions with receptor activator of nuclear factor kappaB ligand (RANKL) and RANK.

Théoleyre S, Kwan Tat S, Vusio P, Blanchard F, Gallagher J, Ricard-Blum S, Fortun Y, Padrines M, Rédini F, Heymann D.

Biochem Biophys Res Commun. 2006 Aug 25;347(2):460-7. Epub 2006 Jun 30.PMID: 16828054 [PubMed - indexed for MEDLINE]Related articles

Serum OPG and RANKL levels before and after intravenous bisphosphonate treatment in Paget's disease of bone.

Martini G, Gennari L, Merlotti D, Salvadori S, Franci MB, Campagna S, Avanzati A, De Paola V, Valleggi F, Nuti R.

Bone. 2007 Feb;40(2):457-63. Epub 2006 Sep 18.PMID: 16979395 [PubMed - indexed for MEDLINE]Related articles

RANKL protein is expressed at the pannus-bone interface at sites of articular bone erosion in rheumatoid arthritis.

Pettit AR, Walsh NC, Manning C, Goldring SR, Gravallese EM.

Rheumatology (Oxford). 2006 Sep;45(9):1068-76. Epub 2006 Feb 20.PMID: 16490750 [PubMed - indexed for MEDLINE]Related articlesFree article

The RANKL/RANK/OPG pathway.

Boyce BF, Xing L.

Curr Osteoporos Rep. 2007 Sep;5(3):98-104.PMID: 17925190 [PubMed - indexed for MEDLINE]Related articles

Serum osteoprotegerin and receptor activator of nuclear factor-kappaB ligand (RANKL) concentrations in allogeneic stem cell transplant-recipients: a role in bone loss?

Kananen K, Volin L, Laitinen K, Ruutu T, Välimäki MJ.

Osteoporos Int. 2006;17(5):724-30. Epub 2005 Dec 31.PMID: 16437190 [PubMed - indexed for MEDLINE]Related articles

Identification of the osteoprotegerin/receptor activator of nuclear factor-kappa B ligand system in gingival crevicular fluid and tissue of patients with chronic periodontitis.

Lu HK, Chen YL, Chang HC, Li CL, Kuo MY.

J Periodontal Res. 2006 Aug;41(4):354-60.PMID: 16827732 [PubMed - indexed for MEDLINE]Related articles

Immunohistochemical localization of RANK, RANKL and OPG in healthy and arthritic canine elbow joints.

Spahni AI, Schawalder P, Rothen B, Bosshardt DD, Lang N, Stoffel MH.

Vet Surg. 2009 Aug;38(6):780-6.PMID: 19674422 [PubMed - indexed for MEDLINE]Related articles

Circulating levels of osteoprotegerin and receptor activator of NF-kappaB ligand in patients with chronic renal failure.

Shaarawy M, Fathy SA, Mehany NL, Hindy OW.

Clin Chem Lab Med. 2007;45(11):1498-503.PMID: 17970704 [PubMed - indexed for MEDLINE]Related articles

Continuous RANKL inhibition in osteoprotegerin transgenic mice and rats suppresses bone resorption without impairing lymphorganogenesis or functional immune responses.

Stolina M, Dwyer D, Ominsky MS, Corbin T, Van G, Bolon B, Sarosi I, McCabe J, Zack DJ, Kostenuik P.

J Immunol. 2007 Dec 1;179(11):7497-505.PMID: 18025194 [PubMed - indexed for MEDLINE]Related articlesFree article